BioSpace News Archive

The strategic investment in Devicare complements Advanced MedTech’s product portfolio and strengthens its leadership in urology and kidney stone management

FUJIFILM Corporation is making an investment of more than 200 Billion yen to establish a new large-scale cell culture production site in the United States to accelerate the growth of its biopharmaceutical contract development and manufacturing business.

Efficient versatile ready-for-rapid building system of negative pressure room MCM will serve as both a triage unit and bridge center in emergency medical situations

Cybin Inc. ( NEO:CYBN ) (“ Cybin ” or the “ Company ”), a life sciences company focused on psychedelic pharmaceutical therapies, is pleased to provide an update on its on its eight patent filings, which cover the Company’s novel therapeutics, delivery mechanisms and treatment regiments. Cybin’s updated corporate presentation will be available at www.cybin.com . The Company is also pleased to announce that it intends to ex

Monteris Medical, the leader in MRI-guided laser interstitial thermotherapy, announced that health insurance provider Health Care Service Corporation, one of the largest independent licensees of Blue Cross and Blue Shield Association®, has updated its medical coverage policy allowing access to the minimally invasive laser ablation procedure for brain tumors and epilepsy when medically necessary.

Biomea Fusion, Inc., a precision oncology company dedicated to developing innovative medicines targeting genomically defined alterations in both hematologic and solid cancers, announced the closing of a $56 million Series A financing.

Protective face masks, since over the past few years have been more of a necessity in the industrial realm for safety and security against high-risk contaminations and accidents.

As the resurgence of COVID-19 activity continues in Canada, we are tracking a range of epidemiological indicators to monitor where the disease is most active, where it is spreading and how it is impacting the health of Canadians and public health, laboratory and healthcare capacity.

-- Focuses on immuno-oncology -- Creates innovative, engineered T and NK cells from induced pluripotent stem cells (iPSC) -- In-licenses mRNA technologies developed by Factor Bioscience -- Uses mRNA-based approach to create cell therapies - avoids viruses and DNA -- Names key executives including Gregory Fiore, MD, as Chief Executive Officer

Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company focused on developing adeno-associated virus (AAV) based gene therapies for the treatment of rare inherited diseases, today announced that Sue Washer, President & Chief Executive Officer, will participate in a fireside chat at the H.C. Wainwright Virtual BioConnect Conference held January 11 – 14, 2021.